BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2013
View Archived Issues
Investigation of EPAC as a therapeutic target expands
Read More
A novel fusion protein inhibits IgE-mediated peanut allergy anaphylaxis in vitro and in vivo
Read More
French researchers design novel immunocytokines
Read More
ATR kinase inhibitors patented by Vertex Pharmaceuticals
Read More
Metabolys divulges novel glucose-lowering agents
Read More
Novel tyrosine-protein kinase SYK inhibitors reported in Takeda patent
Read More
Novartis patent reveals p53/Mdm2 interaction inhibitors
Read More
Incyte reports development of novel JAK inhibitors
Read More
TRPM7 inhibitors reported in NoNO patent
Read More
NIH launches program to find biomarkers for Parkinson's disease
Read More
Paladin Labs enters into agreement for novel neuroblastoma drug
Read More
QRxPharma and FDA confirm steps for resubmission of MoxDuo NDA
Read More
FDA will not meet action date for Ravicti NDA
Read More
FDA grants priority review for afatinib in NSCLC with an EGFR mutation
Read More
DTRA award supports PsiOxus' development of biodefense vaccine adjuvants
Read More
Health Canada approves Afinitor for advanced breast cancer
Read More
Novel inhibitor of JMJD2 histone demethylases reduces viral reactivation in vivo
Read More
siRNAs against serotonin 5-HT1A receptors produce antidepressant-like effects
Read More
Enrollment open in phase II study of Bendavia
Read More
Promising topline results from proof-of-concept burns trial of human skin substitute
Read More
FDA approves Protein Sciences' Flublok seasonal influenza vaccine
Read More
AT-13148 begins U.K. phase I study for cancer
Read More
Somatuline launched in Japan
Read More
Topline results from phase III heart failure study of Aranesp reported
Read More
Pierre Fabre and Maruho sign Japanese licensing agreement for pediatric beta-blocker
Read More